Target & Activity
| Target | Activity | Value |
|---|---|---|
| BD2 (Cell-free assay) | 0.51 μM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| 697 | EC50 | > 5 μM | Cytotoxicity against human 697 cells assessed as reduction in cell viability after 5 days by CellTiter-Glo assay | [PMID: 29170024] |
| A-375 | IC50 | 240.9 μM | Antiproliferative activity against human A375 cells assessed as reduction in cell growth measured after 48 hrs by MTT assay | [PMID: 30926312] |
| A549 | IC50 | 53.1 μM | Antiproliferative activity against human A549 cells assessed as reduction in cell growth measured after 48 hrs by MTT assay | [PMID: 30926312] |
| CCRF-CEM | EC50 | > 5 μM | Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability incubated for 72 hrs | [PMID: 35348328] |
| DLD-1 | IC50 | > 10 μM | Antiproliferative activity against human DLD1 cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay | [PMID: 32153186] |
| HCT-116 | IC50 | 12.83 μM | Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay | [PMID: 32153186] |
| HepG2 | IC50 | 103 μM | Antiproliferative activity against human HepG2 cells assessed as reduction in cell growth measured after 48 hrs by MTT assay | [PMID: 30926312] |
| HL-60 | IC50 | > 20 μM | Cytotoxicity against human HL60 cells assessed as decrease in cell viability after 24 hrs by MTT assay | [PMID: 27266999] |
| HT-29 | IC50 | 235.8 μM | Antiproliferative activity against human HT-29 cells assessed as reduction in cell growth measured after 48 hrs by MTT assay | [PMID: 30926312] |
| K562 | EC50 | > 5 μM | Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs | [PMID: 35348328] |
| L02 | IC50 | > 100 μM | Cytotoxicity against human LO2 cells assessed as reduction in cell growth measured after 24 hrs by MTT assay | [PMID: 30926312] |
| LOUCY | EC50 | > 5 μM | Cytotoxicity against human Loucy cells assessed as reduction in cell viability after 5 days by CellTiter-Glo assay | [PMID: 29170024] |
| MCF7 | IC50 | > 300 μM | Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth measured after 48 hrs by MTT assay | [PMID: 30926312] |
| MCF7 | IC50 | 140.1 μM | Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay | [PMID: 29172540] |
| MDA-MB-231 | IC50 | 155.4 μM | Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay | [PMID: 29172540] |
| MOLM-14 | EC50 | 6.7 μM | Cytotoxicity against human MOLM-14 cells assessed as reduction in cell viability incubated for 72 hrs | [PMID: 35348328] |
| MV4-11 | IC50 | > 20 μM | Cytotoxicity against human MV4-11 cells assessed as decrease in cell viability after 24 hrs by MTT assay | [PMID: 27266999] |
| MV4-11 | IC50 | 4.48 μM | Antiproliferative activity against human MV4-11 cells after 72 hrs by MTT assay | [PMID: 28765013] |
| NALM-6 | EC50 | > 5 μM | Cytotoxicity against human NALM6 cells assessed as reduction in cell viability after 5 days by CellTiter-Glo assay | [PMID: 29170024] |
| NB-4 | EC50 | > 5 μM | Cytotoxicity against human NB-4 cells assessed as reduction in cell viability incubated for 72 hrs | [PMID: 35348328] |
20 records · Scroll to view more